Swiss MedUnion is a "one-stop shop" in the growing medical cannabis industry, covering all stages of the value chain from import to storage, including transport management, wholesale, and GMP Certification for all products. The company offers contract logistics and packaging services, as well as support in communication with authorities and certification processes. Founded in 2021, the company's ambition is to provide more patients access to cannabis therapy. With main locations in Zurich, Switzerland and London, UK, and ports across Europe, Swiss MedUnion operates in the Manufacturing and Pharmaceutical industries. With no reported past investments, Swiss MedUnion presents an opportunity for venture capital investors looking to enter the burgeoning medical cannabis market.
There is no investment information
No recent news or press coverage available for Swiss MedUnion .